COVID-19血栓炎症:将炎症性纤维素添加到拼图中
Elena Magrini1, Cecilia Garlanda2
1IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.
Trends in immunology
|September 26, 2024
概括
SARS-CoV-2 尖端蛋白因与纤维素素相互作用而引发血栓和炎症,这是一种涉及COVID-19和长期COVID的过程. 在小鼠中准这种炎症性可以防止凝血和神经损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 病理学 病理学 病理学
背景情况:
- 血栓炎症是急性COVID-19的一个关键因素,并导致长期COVID.
- SARS-CoV-2 病毒利用特定的蛋白质来驱动疾病的致病性.
研究的目的:
- 为了研究SARS-CoV-2尖端蛋白和纤维原蛋白之间的相互作用.
- 了解这种相互作用在纤维素聚合和炎症中的作用.
- 评估针对这种途径的治疗策略.
主要方法:
- 生物化学试验分析尖端蛋白质-纤维素原相互作用.
- 在小鼠模型中的体内研究,以评估凝血和神经病理学.
- 基于的抑制炎症性纤维素的形成.
主要成果:
- 在SARS-CoV-2尖端蛋白和纤维素原之间展示了直接相互作用.
- 证实这种相互作用促进纤维素聚合和炎症活性.
- 表明,准炎症性纤维素可以保护小鼠免受尖端依赖的凝血和神经病理.
结论:
- SARS-CoV-2尖端蛋白与纤维素原相互作用是COVID-19中血栓炎症的关键驱动因素.
- 抑制这种相互作用为管理COVID-19并发症提供了潜在的治疗方法,包括神经病理学.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
Extrinsic and Intrinsic Pathways of Hemostasis
6.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.4K
Venous Thrombosis I: Introduction
3
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
3
Clot Retraction and Fibrinolysis
4.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.8K
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Inflammation
53.2K
Overview
53.2K


